Canurta Journal
A collection of news, scientific papers and impact across industry, academia and events.
Cannabinoids as Potential Therapeutics for ALS: An Overview from Preclinical and Clinical Studies
Optimization of Cannflavin Production in Germinated Hemp Seeds: Insights into Metabolomic and Antioxidant Profiles
Medical Marijuana for ALS Symptom Management: Potential Benefits and Risks in Disease Progression
Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways
The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition
Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism
Exploring Cannabis Pharmacology: Beyond THC and CBD
The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells
Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents
The Antiatherogenic Potential of Flavonoids in Cardiovascular Health
Cannflavin A Displays Both a Hormetic and Neuroprotective Profile Against Alzheimer's Disease Progression
Preclinical Research with a First-in-Class ALS Therapy Formulation
Reflecting on the ALS Drug Development Summit in Boston
The Comprehensive Neurotherapeutic Potential of Cannabis sativa
Chemistry and Activities of Cannflavins
Innovating Plant Flavonoid Production
Can Cannflavins Treat Brain Cancer? Study Shows Molecules Have the Potential to Attack Tumour Cells
Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes
Canurta Establishes a New Standard in Hemp Extract Analysis
Cannflavins isolated from Cannabis Sativa impede Caenorhabditis Elegans Response to Noxious Heat